Clin Ophthalmol. 2009;3:57-67. Epub 2009 Jun 2.

The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca.

Source

Department of Ophthalmology, Erciyes University School of Medicine, Kayseri, Turkey.

Abstract

PURPOSE:

To review and integrate recent advances in identifying the role of inflammation in the pathogenesis of dry eye conditions and the biological rationale and practical clinical aspects of newer, antiinflammatory theories.

METHODS:

A comprehensive literature survey.

RESULTS AND CONCLUSION:

Keratoconjunctivitis Sicca (KCS) is a multifactorial and complex disorder in which ocular surface inflammations play a central role. Identification of specific CD4-T-Cell pathways and the recent recognition of targeting of alpha-fodrin suggest a case for novel new therapeutic aspects such as anti-CD4 monoclonal antibodies, systemic linoleic and gamma-linolenic acids, and omega-6 essential fatty acids. Replacement of tear volume with nonpreserved wetting agents and standard typical antiinflammatory corticosteroid and/or cyclosporine A continues to be central current conventional therapy for KCS.

PMID:: 19668545; [PubMed]
PMCID:: PMC2709015

Free PMC Article

Images from this publication.See all images (1) Free text

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Review Antiinflammatory therapy for dry eye. [Am J Ophthalmol. 2004]
Review Antiinflammatory therapy for dry eye.
Pflugfelder SC. Am J Ophthalmol. 2004 Feb; 137(2):337-42.
Review Advances in the diagnosis and management of keratoconjunctivitis sicca. [Curr Opin Ophthalmol. 1998]
Review Advances in the diagnosis and management of keratoconjunctivitis sicca.
Pflugfelder SC. Curr Opin Ophthalmol. 1998 Aug; 9(4):50-3.
Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients. [Ophthalmology. 2006]
Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
Lee HK, Ryu IH, Seo KY, Hong S, Kim HC, Kim EK. Ophthalmology. 2006 Feb; 113(2):198-205. Epub 2005 Dec 19.
Review The diagnosis and management of dry eye: a twenty-five-year review. [Cornea. 2000]
Review The diagnosis and management of dry eye: a twenty-five-year review.
Pflugfelder SC, Solomon A, Stern ME. Cornea. 2000 Sep; 19(5):644-9.
Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome. [Ophthalmology. 1999]
Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome.
Marsh P, Pflugfelder SC. Ophthalmology. 1999 Apr; 106(4):811-6.

See reviews... See all...

Cited by 1 PubMed Central article

A review on recent advances in dry eye: Pathogenesis and management. [Oman J Ophthalmol. 2011]
A review on recent advances in dry eye: Pathogenesis and management.
Bhavsar AS, Bhavsar SG, Jain SM. Oman J Ophthalmol. 2011 May; 4(2):50-6.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The role of inflammation and antiinflammation therapies in keratoconjunctivitis ...
The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca.
Clin Ophthalmol. 2009 ;3:57-67. Epub 2009 Jun 2 .

PubMed
Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes.
Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes.
Clin Ophthalmol. 2007 Dec ;1(4):441-53.

PubMed
Levobetaxolol hydrochloride: a review of its pharmacology and use in the treatme...
Levobetaxolol hydrochloride: a review of its pharmacology and use in the treatment of chronic open-angle glaucoma and ocular hypertension.
Clin Ophthalmol. 2007 Jun ;1(2):93-7.

PubMed
Collagen cross-linking: Strengthening the unstable cornea.
Collagen cross-linking: Strengthening the unstable cornea.
Clin Ophthalmol. 2008 Dec ;2(4):863-7.

PubMed
Molecular markers of susceptibility to ocular toxoplasmosis, host and guest beha...
Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly.
Clin Ophthalmol. 2008 Dec ;2(4):837-48.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: